跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NF-kappaB inhibitors (inflammatory diseases)
首页
药物
NF-kappaB inhibitors (inflammatory diseases)
NF-kappaB inhibitors (inflammatory diseases)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
Inhibitors of transcription factor NF-kappaB
申请人: SMITHKLINE BEECHAM CORP
优先权: 2000
US
3 件公开
Treatment of inflammatory and autoimmune diseases
申请人: ELLIOTT PETER J
优先权: 2001
US
MYRICERIC ACID DERIVATIVES FOR THE TREATMENT OF CANCER, CARDIOVASCULAR AND INFLAMMATORY DISEASES
申请人: SAVIPU PHARMACEUTICALS
优先权: 2007
US
2 件公开
ENRICHED FRACTIONS FROM CLARY SAGE FOR THE TREATMENT OF CANCER, CARDIOVASCULAR AND INFLAMMATORY DISEASES
申请人: SAVIPU PHARMACEUTICALS
优先权: 2008
US
Method of treating inflammation with HIV-1 protease inhibitors and their derivatives
申请人: CEDARS SINAI MEDICAL CENTER
优先权: 2002
US
NF-kappaB inhibitors and uses thereof
申请人: UNIV MICHIGAN STATE
优先权: 2003
US
2 件公开
NF-kappaB inhibitors and uses thereof
申请人: UNIV MICHIGAN STATE
优先权: 2003
US
3 件公开
药物
反馈
